Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Organic Letters|March 22, 2001
Improved solid-phase peptide synthesis method utilizing alpha-azide-protected amino acidsJ T Lundquist, J C PelletierBioorganic & Medicinal Chemistry Letters|September 25, 1999
Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analoguesJ T Lundquist, T A DixJournal of Medicinal Chemistry|December 2, 1999
Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysineJ T Lundquist, T A DixBioorganic & Medicinal Chemistry Letters|April 1, 2000
Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinitiesJ T Lundquist, E E Büllesbach, T A DixThe Journal of Peptide Research : Official Journal of the American Peptide Society|March 22, 2002
Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogsJ T Lundquist, E E Büllesbach, P L Golden, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Tricyclic ureas: a new class of HIV-1 protease inhibitorsW Han, J C Pelletier, C N HodgeThe Journal of Peptide Research : Official Journal of the American Peptide Society|May 8, 2000
Design rationale, synthesis, and characterization of non-natural analogs of the cationic amino acids arginine and lysineK J Kennedy, J T Lundquist, T L Simandan, et al.Organic Letters|June 3, 2000
7-Azabicycloheptane carboxylic acid: a proline replacement in a boroarginine thrombin inhibitorW Han, J C Pelletier, L J Mersinger, et al.Harvard Business Review|August 6, 1993
Strategy and the art of reinventing valueK van der Heijden, M Maccoby, N Hama, et al.Pageof 1